Non-Melanoma Skin Cancers Coverage from Every Angle

Published Medical Literature

Pembrolizumab Therapy for Inoperable Case of Squamous Cell Carcinoma
Does a Family History of Melanoma Increase the Risk of Keratinocyte Cancers?
Risk Factors for Non-Melanoma Skin Cancers in Recipients of Kidney Transplant
Case Study: Rare Keratoacanthoma and Presence of HPV39
Patterns of Major Surgery for Cutaneous Squamous Cell Carcinoma
Use of Avelumab in Merkel Cell Carcinoma: Linking Early Response With Overall Survival
Meta-analysis of Treatment of Skin Cancers With PD-1/PD-L1 Inhibitors
Quality of Life With Vismodegib Treatment of Non-Melanoma Skin Cancers
Standardized Total Body Skin Exam: Improved Accuracy and Efficiency?
Physicians Versus Machine-Learning Algorithms in Classifying Pigmented Skin Lesions
Factors Affecting Survival for Patients with Advanced Cutaneous Squamous Cell Carcinoma
Does PD-1 Expression Differ by Histology in Cutaneous Squamous Cell Carcinoma?
Treatment Patterns for Canadian Patients With Head and Neck Squamous Cell Carcinoma
Multikinase Inhibitor Shows Activity in Aggressive Subtype of Squamous Cell Carcinoma
Predicting Response to Immunotherapy in Squamous Cell Carcinoma
Link Between Skin Cancer Diagnosis and Health-Care Screening Practices
Molecular Role of Complement C3a in Cutaneous Squamous Cell Cancer
Does Squamous Cell Carcinoma Risk Change With Immunosuppression?
Extremity Nevus Count and Risk of Skin Cancers
Association of Indoor Tanning and Skin Cancer in Canada
Is There an Association Between Skin Cancer and Erectile Dysfunction Medications?
Keratinocyte Carcinoma: Update on Treatment and Prevention
Intermittent Vismodegib Regimen for Locally Advanced Basal Cell Carcinoma
Use of Pembrolizumab in First-Line Treatment of Merkel Cell Carcinoma
Comparing Staging Systems in Cutaneous Squamous Cell Carcinoma
Impact of HLA Antigen Mismatches on Skin Cancer Risk in Transplant Recipients
Use of Cetuximab in Multimodality Treatment of Cutaneous Squamous Cell Carcinoma
Factors Contributing to Recurrence of Invasive Squamous Cell Carcinoma
How BMI Interacts With Sun Exposure and Risk of Non-Melanoma Skin Cancer
Using Immunohistochemical Panel to Differentiate Basal Cell Carcinoma and Trichoepithelioma
Risk Factors of Aggressive Skin Cancer in Recipients of Solid Organ Transplants
Research Points to Certain Genetic Links to Cutaneous Squamous Cell Carcinoma
Organ Transplantation and Degree of Differentiation of Cutaneous Squamous Cell Carcinoma
Risk of New Skin Neoplasms in Patients With History of Skin Cancer
Merkel Cell Carcinoma: Need for Timely Diagnosis and Treatment
Study Sheds Light on Cellular Origin of Merkel Cell Carcinoma
Are Some Transplant Recipients Exposed to Voriconazole at Risk for Skin Cancer?
Impact of Tumor Board Conferences on Treatment of Skin Cancer
Master Transcription Factors in Progression of Squamous Cell Carcinoma
Mohs Surgery for High-Risk Squamous Cell Carcinoma
Could Gentian Violet Be Used to Treat Cutaneous T-Cell Lymphoma?
Comparing Outcomes of Different Basal Cell Carcinoma Treatments
MAVORIC Results Support FDA Approval of Mogamulizumab in Cutaneous C-Cell Lymphoma
Case Study Highlights Novel Concurrent Therapy for Cutaneous Squamous Cell Carcinoma
Impact of Non‐Melanoma Skin Cancers on Patients’ Quality of Life
Update on Nonsurgical Treatments of Non-Melanoma Skin Cancer
Identifying Sentinel Lymph Nodes in Merkel Cell Cancer With Indocyanine Green
Do Frequent Occurrences of Basal Cell Carcinoma Increase Risk for Other Cancers?
Do UVA Nail Lamps Pose Cutaneous Carcinogenic Risk?
Identifying Renal Transplant Patients at Risk for Squamous Cell Carcinoma by DNA Methylation of T Cells
Depth of Follicular Involvement in Invasive Squamous Cell Carcinoma
Does Renal Transplant Rejection Influence Risk of Developing Squamous Cell Carcinoma?
Delayed Skin Reactions Reported With PD-1 Inhibitors
Comparison of Photodynamic Therapies for Active Keratosis
New Guidelines for Treating Metastatic Merkel Cell Carcinoma: Focus on Immunotherapy
Squamous Cell Carcinoma of the Lip: Is There a Difference Between Vermilion vs Cutaneous Involvement?
First-Line Avelumab for Metastatic Merkel Cell Carcinoma
Is There a Link Between Skin Cancers and Alzheimer’s Disease?
AAD Guidelines for Non-Melanoma Skin Cancers
Workplace UV Exposure = Quantifiable Economic Costs
Melanoma Mortality Risk and Nonmelanoma Cancer History: Is There a Connection?

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.